Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Weekly Topotecan in Recurrent Ovarian Cancer
NCT01600573Phase 2Unknown
- Start
- May 2012
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC). Status: unknown.
02
Drugs
pazopanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT01600573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600573.